N
The startup develops a rapid diagnostic test that combines the sensitivity and specificity of PCR with the speed of antigen tests to detect pneumonia-causing superbugs. This technology enables clinicians to quickly prescribe effective antibiotics, preventing the progression of pneumonia into an incurable condition.
Updated 3 months ago
Funding
$860K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a rapid diagnostic test that combines the sensitivity and specificity of PCR with the speed of antigen tests to detect pneumonia-causing superbugs. This technology enables clinicians to quickly prescribe effective antibiotics, preventing the progression of pneumonia into an incurable condition.